Hop-derived iso-a-acid (IAA) ingredient congeners are specific to beer. Concentrations of IAAs were determined in blood of five volunteers over 6 h following the consumption of small volumes of beer containing relatively high (Pale Ale beer) or low (wheat beer) concentrations of IAAs. IAAs were quickly absorbed with peak trans-IAA concentrations at 0.5 h followed by a drop of generally 10-fold at 2 h and low or not detectable trans-IAA levels at 6 h. However, the qualitative monitoring showed that the cis-IAAs were detected at all time-points. Preliminary pharmacokinetics of these compounds in humans shows relatively small interindividual differences and an estimated short half-life of ∼30 min. Comparison of 0.5 and 2 h blood specimens demonstrated that the trans isomers were eliminated faster than the cis counterparts. Preliminary urine analysis showed only unmodified 'co' analytes detectable throughout the 6 h. In authentic forensic casework where typically large amounts of conventionally hopped beer are consumed, this approach may provide a novel method to target ingredient congeners consistent with beer ingestion.
Introduction
Iso-a-acids (IAAs) are derived from the hop plant (Humulus lupulus L.) and are present in beer following the isomerization of a-acids (AAs) during the boiling phase of the brewing process. Six stereoisomers of IAAs are produced from the three predominant AA analogs (co, n and ad) that each isomerize into diastereoisomers ( Figure 1 ). The compounds are structurally very similar, only differing in the nature of the saturated acyl side-chain and the absolute configuration of one of the chiral centers (1) .
Beers commonly contain 6 -30 International Bitterness Units (IBUs, one unit being approximately equal to 1 mg/L of total IAA); however, certain styles of 'highly hopped' craft beers often contain much higher amounts (2, 3) . The cis : trans ratios in beer are usually 68 : 32 (4) . However, the trans-IAAs are present in the foam in greater proportion than the cis-IAAs due to their lower water solubility, which also explains the lower halflife of the trans-IAAs (,1 year) compared with the cis-IAAs ( 5 years) during beer storage (5) . The long-term stabilities of the IAA in stored blood recently concluded that the IAA 'n' analogs were most susceptible to degradation; however, refrigeration and freezing provided acceptable stability (6) .
It has been proposed that due to the IAA content, beer may also have medicinal properties, including weight loss, antidiabetic, anticarcinogenic and anti-inflammatory (7 -14) ; animal models show that diets enriched with IAAs and administered orally to mice (7 -9) and rats (10) , led to physiological changes; suggesting that these compounds may be bioavailable. Furthermore, IAAs were dosed to New Zealand white rabbits where it was determined that the total bioavailability of IAA was 13.0%, of which diastereomerization showed no influence; however, the more lipophilic 'n' analogs showed greater bioavailability compared with other analogs (12) . More recently using human in vitro models, IAAs were shown to be highly permeable across Caco-2 intestinal cells (15) , while also shown to promote gastric acid secretion in human gastric cancer cells (16) . The AA compounds, of which IAAs originate from and are structural similar, were shown to permeate epithelial membranes and demonstrate absorption also in human in vitro models (15) .
Recently, these IAAs have been detected in blood of one volunteer following the consumption of a high-hopped beer using an ultra-high performance liquid chromatography -tandem mass spectrometry (UHPLC -MS-MS) procedure (17) . This confirmation of beer consumption method specifically targets and quantifies the trans stereoisomers of the IAA group, whereas the cis counterparts are qualitatively monitored (Figure 1 ). Detection of all IAA analytes were present at 0.5 and 2 h post-dose with trans-IAA concentrations of 0.2 and 0.02 mg/L, respectively. This pilot study demonstrated that these compounds were bioavailable and suggested the possible applicability for clinical and forensic toxicological casework.
This may represent another method of performing alcohol congener analysis to confirm the consumption of beer in routine forensic casework and in after-drinking (or hip-flask) defense cases where the feasibility of claimed alcohol consumption prior and/or subsequent to a motor vehicle incident is in question (18 -21) .
The aim of this study was to detect and determine the pharmacokinetics of IAAs in the blood and urine of human volunteers given controlled doses of two types of beer containing different amounts of IAAs.
Experimental
Drinking study design Five healthy male volunteers were administered specific volumes of a relatively high-hopped beer (Little Creatures Pale Ale from Perth, Australia) and a relatively low-hopped beer (Erdinger Weissbier from Erding, Germany; Table I ). Studies were performed separately over a day each with a wash-out period of at least 1 week between studies, and no alcohol was permitted for 48 h prior to each of the study days.
To estimate blood alcohol concentration (BAC), a revised version of the Widmark formulae by Posey et al. was employed that mathematically combines recent variations by other authors into a single formula to provide an accurate 'Widmark factor' for each individual and subsequently the volume of beer required to produce a peak BAC of 0.05 g/100 mL, the legal limit in Australia (21) (22) (23) . The anthropometric measurements (i.e., height, weight and age) of each participant are described in Table II. Blood was obtained by a registered phlebotomist and urine by the volunteers themselves at prior (zero), 0.5, 2 and 6 h postconsumption time-points. The 0-h specimens acted as the control and blank blood and urine of the respective participant. In order to minimalize absorption variables, all participants fasted from food on the morning of the study and the administered beer Isomerization of a-acid to iso-a-acids in diasteroisomeric cis and trans forms after boiling of the wort, including the three major analogs. Widmark factor, an estimate of the volume of distribution calculated using the anthropometric measurements of the volunteers.
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Specimens
Preserved blank blood (10 mL of samples containing 200 mg sodium fluoride and 30 mg potassium oxalate) for instrument calibration purposes were obtained from a local blood bank (Melbourne, Australia). Blood of the participants in the drinking studies were collected in sterile 5-mL Venosafe blood tubes containing 9 mg sodium fluoride and 9 mg potassium oxalate purchased from Hazpak (Melbourne, Australia). Blank urine for instrument calibration purposes was obtained from the authors after abstinence from beer and other alcoholic beverages for 1 week. Blank and volunteer urine specimens were contained in 50 mL of urine pots and stored at 2208C until analysed.
Chemicals and reagents
The trans-IAA reference standards were DCHA-Iso, ICS-I3 (containing 62.3% w/w of trans-IAA), obtained from Labor Veritas (Zurich, Switzerland) and contain primarily trans-isocohumulone, trans-isohumulone and trans-isoadhumulone that were grouped and quantified together (trans-IAA). However, during commercial production, residual cis-IAAs remain and were utilized to qualitatively monitor cis-isocohumulone, cis-isohumulone and cis-isoadhumulone (Figure 1) .
The isotope-labeled internal standard nimodipine-d 7 was purchased from PM Separations (Brisbane, Australia). Acetonitrile (ACN), methanol and formic acid were purchased from Merck (Melbourne, Australia). Ammonium formate was purchased from Sigma-Aldrich (Sydney, Australia). All chemicals were of analytical grade or better, and water was purified using a Milli-Q Ultrapure Water System from Waters (Sydney, Australia).
IAA analytical method IAA determination was performed using a previously published UHPLC -MS-MS method that was validated for blood analysis (17) . Briefly, the extraction consisted of a protein precipitation of 200 mL of whole blood using 2208C ACN with the resulting supernatant dried under nitrogen and the residue reconstituted with 50 mL of a mixture of eluent A and eluent B (60 : 40, v : v). Urine analysis was performed using this method, replacing blood for urine in the calibration model.
The UHPLC-MS-MS system comprised of a Shimadzu MS 8030 quadrupole mass spectrometer (Melbourne, Australia) operated in the electrospray ionization in negative mode and a Shimadzu Nexera UHPLC system (Melbourne, Australia) that consisted of a degasser, two eluent pumps, a column oven (308C) with a Kinetex C 18 column (3.0 Â 150 mm, 2.6 mm) and a chilled autosampler. For MS data evaluation, Shimadzu Postrun and Shimadzu Browser Analysis (Melbourne, Australia) softwares were used. GraphPad Prism 5.04 from GraphPad Software (San Diego, CA, USA) was used for statistical analysis. The mobile phases consisted of 50 mmol/L of aqueous : ACN (90 : 10) ammonium formate pH 2.8 (eluent A) and ACN containing 0.1% formic acid (eluent B).
Preparation of stock solutions, calibration standards, quality controls, stability samples and extraction procedures were performed as published previously (17) .
Blood alcohol analysis
Blood alcohol analysis was undertaken in conjunction with routine blood alcohol analysis within the Toxicology Department at the Victorian Institute of Forensic Medicine. Twenty-five microliters of blood were diluted with 1,000 mL of deionized water and directly injected into a gas chromatograph coupled with flame ionization detection and a packed glass column (0.2% carbowax 1500 on carbopack C 80/100 mesh, Sigma-Aldrich) for separation and quantification. This method has been in use for over two decades, utilizes daily calibrations and ensures all quality controls are within range.
Ethics
Approval for the human consumption of beer and subsequent specimen retrieval and analysis was obtained from the Ethics Committee of the Victorian Institute of Forensic Medicine (EC 04/2012).
Results
The IAA content of the two beers and their sources are shown in Table I . Neither alcohol nor IAA analytes were detected in any of the pre-dose blood or urine specimens.
Following the consumption of 600 -800 mL of relatively high-hopped beer, the trans-IAAs were detected in all post-dose blood specimens (Figure 2 ). IAA concentrations peaked at 0.5 h in all volunteers. Results were similar between participants with the trans-IAA reaching 0.1 mg/L at 0.5 h and dropping to 0.01 -0.02 mg/L by 2 h with only one participant having trans-IAA detected at the final 6-h time-point.
Consumption of the low-hopped beer showed trans-IAA levels also peaking at 0.5 h, although at a lower 0.02 mg/L concentration compared with a higher hopped beer. At 2 h, these concentrations had dropped to 0.002 mg/L, just above the lower limit of quantification. In both studies, the trans-IAA levels fell 10-fold from 0.5 to 2 h. This rate of decrease in both studies after 90 min suggests a trans-IAA half-life (t ½) of 30 min.
cis-IAAs were detected in the 0.5-, 2-and 6-h blood specimens of all participants in both high-and low-hopped studies, of which the 'co' analog was consistently most abundant (data not shown). Since the 'co' analogs were the most abundant ions monitored and were therefore the best analogs to demonstrate variations in elimination between stereoisomers. Figure 3 shows the two 'co' analytes within the IAA group (trans-isocohumulone and cis-isocohumulone) and compares the areas of these analytes at the 0.5-and 2-h time-points. Results show that levels of the trans isomer fell 5-10% more in the 90-min timespan in both studies, suggesting that the trans isomers may be eliminated more rapidly. Notable differences in the ratios between studies of 10% were also observed in the low-hopped study. The mean and standard deviation of trans-IAA, BAC and the comparison of trans and cis metabolism results for the five participants in both studies are shown in Table III .
Analysis of urine for trans-IAA showed only the 'co' analogs detected in volunteers at all time-points in the high-hopped study. Although quantification is not possible due to the detection of only one analog, there was a noticeable variation in the area responses between volunteers. Only one volunteer in the lowhopped beer study had a detectable trans 'co' analog (at 0.5 h). No 'n' or 'ad' analogs were detected in any volunteer at any timepoint. However, the cis-IAA 'co' analog was detected in all volunteers in both studies at all time-points post-consumption.
Discussion
Although one volunteer had given detectable concentrations of IAAs after consumption of a high-hopped beer in a pilot study (17) , the pharmacokinetics of IAAs in the blood of humans have not yet been established. This current study provided some basic pharmacokinetic information on IAAs, largely in agreement with previous animal models that demonstrated that IAA was rapidly absorbed, had a t ½ of 32 + 1.8 min and only trace amounts of unmodified IAAs were excreted in the urine (12) .
Interindividual differences in pharmacokinetics were small as trans-IAA concentration over time profiles between participants demonstrated no obvious outliers. The low-and high-hopped beers were described as 10 and 40 IBU, respectively; therefore, although similar volumes of the beer were consumed, participants in the low-hopped beer study consumed 4-fold less IAA. This correlated well as the trans-IAA levels between the beer studies showed a similar profile with differences in trans-IAA concentrations of approximately four times. Furthermore, the IBU of the Indian Pale Ale which was consumed in the pilot study was approximately double that of the Little Creatures Pale Ale used in this study (17) . This compared well with the trans-IAA concentrations at 0.5 and 2 h from this current study being approximately half to that of the pilot study.
Although differences between individuals were shown to be small, these data only provide a limited understanding of the pharmacokinetics of these compounds and does not currently permit correlations of trans-IAA and BAC levels to be made or estimate when alcohol consumption occurred. Furthermore, future studies should account for potential gender differences with the inclusion of female volunteers.
As the absorption of ethanol is commonly accepted to provide peak BAC at 1 h post-consumption (24), the 0.5-and 2-h timepoints most likely do not represent the peak BAC and explain the lower than BAC 0.05 g/100 mL target levels observed.
Since the low-hopped wheat beer was described as only 10 IBU and beers naturally contain less trans-IAA than cis, it is expected that the concentrations of trans-IAA in blood to be only a few mg/L. With participants consuming between 600 and 800 mL of Erdinger Weissbier, only 1-3 mg of trans-IAA was estimated to have been consumed, thus making blood IAA detection more difficult. However, confirmation of beer ingestion almost throughout the 6 h demonstrates the sensitivity of the method and possible applicability for the detection of different styles of beers.
Notable differences in the overall trans : cis ratios between studies of 10% less in the low-hopped (Erdinger Weissbier) were observed. This is most likely due to the trans isomer being less stable in beer long term and a slight loss occurring during the transportation from Germany to Australia, rather than any pharmacokinetic variation between beer studies taking place. Figure 3 . The comparison of trans-isocohumulone/cis-isocohumulone area ratios in the blood of the five volunteers at 0.5 and 2 h post-consumption of beer in the highand low-hopped beer drinking studies in order to demonstrate metabolism differences between trans and cis isomers. n/a n/a, not performed at 6 h time-point due to area response below the limit of detection (signal : noise ,3).
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Although no significant differences were detected between stereoisomers during long-term storage in blood (6) , this study demonstrated that the trans isomers may be more subject to metabolism in vivo. Furthermore, the cis isomers are also 1.5 times more abundant in beer to that of the trans counterpart (4) and as previously mentioned, are stable for longer in beer during storage. Finally, the detection of cis-isocohumulone at 6 h post-consumption was possible where trans isomers were not detected. Therefore, it is noteworthy that although the cis isomers were unable to be quantified, they may present as possibly important qualitative markers when greater detection windows of beer consumption are required.
Additional pharmacokinetic information can be obtained with use of the in silico metabolism pathway prediction modeling software such as 'MetaPred', which suggested that the cytochrome P450 (CYP) 2C9 was primarily responsible for the oxidation of the IAA compounds (25) . Furthermore, 'SmartCyp', a CYP-mediated metabolism prediction tool, suggested that the most probable site of metabolism would occur at the end of both side-chains on the four methyl groups (26) . Similarly, Cattoor et al. (12) demonstrated that IAA conjugates were not significantly present in rabbits post-ingestion of large amounts of IAAs and also proposed that Phase I metabolism was the primary pathway for the elimination of IAA.
Preliminary urine analysis showed a significant difference in the elimination of unmodified IAA analogs with the 'co' being the only detectable analog. Although cis-IAA 'co' analytes were able to be abundantly detected, the development of an analytical method for metabolites or conjugates of IAA may allow for longer windows of detection while also providing further information on the metabolism pathways of IAAs.
Reduced IAAs are chemically synthesized from IAAs and are commonly used in either green or clear glass bottles for their photolytic protective properties (2 -4, 12, 13). They may be used in isolation or in conjunction with traditional IAA hopping techniques. Detection of reduced IAAs in blood and urine following the consumption of these beers may allow for further discrimination between the ingestion of different beers. Additionally, determination of accurate IAA concentrations in a range of popular, craft and homemade beers would benefit forensic toxicologists in correlating blood IAA results with the beer(s) suspected to have been consumed.
In conclusion, although outside the scope of this study, more IAA pharmacokinetic data may be achieved with the oral and intravenous dosing of pure IAA formulations and with specimens collected more often. While these studies are limited to five volunteers and two different types of beer, the detection of IAA in blood and perhaps in other specimens may be possible in forensic casework, particularly where typically large amounts of conventionally hopped beer are consumed and the confirmation of beer consumption is valuable.
